Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2300 of 2873 entries
View as:

Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04465162 Org: User:
Start: 06/07/00 End: 03/15/21 Due: 03/15/22

Pain Management Following TRAM Flap for Breast Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00500565 Org: User:
Start: 12/31/03 End: 06/30/08 Due: 06/30/09

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04530487 Org: User:
Start: 08/19/20 End: 08/26/24 Due: 08/26/25

Spousal Support in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00824252 Org: User:
Start: 12/08/08 End: 02/23/22 Due: 02/23/23

Thalidomide-Dexamethasone for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00038090 Org: User:
Start: 06/30/00 End: 05/31/05 Due: 05/31/06

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06744816 Org: User:
Start: 06/05/25 End: 11/30/27 Due: 11/30/28

Lifestyle Intervention for Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00633633 Org: User:
Start: 02/11/08 End: 05/31/26 Due: 05/31/27

Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions

Phase: N/A Priority: Normal
NCT ID: NCT02469779 Org: User:
Start: 12/31/13 End: 02/01/21 Due: 02/01/22

Oral Valganciclovir Versus Valacyclovir

Phase: N/A Priority: Normal
NCT ID: NCT00562770 Org: User:
Start: 09/30/03 End: 07/31/06 Due: 07/31/07

Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study

Phase: N/A Priority: Normal
NCT ID: NCT04645680 Org: User:
Start: 06/24/20 End: 02/28/26 Due: 02/28/27

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00968760 Org: User:
Start: 06/20/11 End: 04/23/20 Due: 04/23/21

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03892993 Org: User:
Start: 04/09/19 End: 08/01/28 Due: 08/01/29

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02282345 Org: User:
Start: 04/16/15 End: 06/07/22 Due: 06/07/23

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06085716 Org: User:
Start: 02/16/24 End: 08/31/29 Due: 08/31/30

Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C

Phase: N/A Priority: Normal
NCT ID: NCT00038649 Org: User:
Start: 06/30/01 End: 11/30/13 Due: 11/30/14

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05042934 Org: User:
Start: 09/15/21 End: 08/30/22 Due: 08/30/23

Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00950001 Org: User:
Start: 08/13/09 End: 04/30/27 Due: 04/30/28

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01409161 Org: User:
Start: 10/05/11 End: 12/18/25 Due: 12/18/26

Study of Pembrolizumab (MK-3475) in Combination With Romidepsin

Phase: N/A Priority: Normal
NCT ID: NCT03278782 Org: User:
Start: 11/14/17 End: 07/31/25 Due: 07/31/26

Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss

Phase: N/A Priority: Normal
NCT ID: NCT03131908 Org: User:
Start: 07/17/17 End: 12/31/25 Due: 12/31/26

Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06045247 Org: User:
Start: 01/05/24 End: 07/31/30 Due: 07/31/31

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00501826 Org: User:
Start: 07/11/07 End: 10/31/26 Due: 10/31/27

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04675710 Org: User:
Start: 06/24/21 End: 10/30/26 Due: 10/30/27

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00506129 Org: User:
Start: 09/30/03 End: 06/30/15 Due: 06/30/16

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT06287515 Org: User:
Start: 01/06/25 End: 07/01/27 Due: 07/01/28